Ischemia-Reperfusion Clinical Trial
Official title:
The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study
The investigators will examine whether administration of certain medications will decrease or prevent ischemia-reperfusion injury.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | |
Est. primary completion date | February 2011 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients undergoing breast reconstruction Exclusion Criteria: - Diabetes mellitus - Kidney or liver disease - Use of immunosuppressants |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Medical Center | Maastricht |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Antioxidant concentrations | 0,5-24 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02254642 -
Effects of Ischemic Preconditioning After Aortic Clamping
|
N/A | |
Completed |
NCT00482469 -
The DIEP-Flap as a Model of Ischemia-Reperfusion
|
N/A |